The inhibition of monoamine oxidase activity by various antidepressants: Differences found in various mammalian species

Japanese Journal of Pharmacology

Volumn 81, Issue 1, 1999, Pages 115-121

  Egashira, Toru ^a   Takayama, Fusako ^a   Yamanaka, Yasumitsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Animal species; Antidepressant; Brain; Monoamine oxidase A; Monoamine oxidase B

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; BRAIN ENZYME; IMIPRAMINE; MAPROTILINE; MITOCHONDRIAL ENZYME; NOMIFENSINE; ZIMELDINE;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; DOG; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MONKEY; MOUSE; NONHUMAN; RAT; SPECIES DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BINDING, COMPETITIVE; BRAIN; DOGS; IMIPRAMINE; ISOENZYMES; KINETICS; MACACA; MALE; MAPROTILINE; MICE; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NOMIFENSINE; RATS; RATS, WISTAR; SPECIES SPECIFICITY; ZIMELDINE;

EID: 0032851058     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.81.115     Document Type: Article

References (15)

1. Coppen A: Indolamines and affective disorders. J Psychiatr Res 9, 163-171 (1972)
2. Prange A, Wilson J and Lynn CW: L-Tryptophan in mania: contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry 30, 56-62 (1974)
3. Roth JA and Gillis CN: Inhibition of lung-, liver-and brain-monoamine oxidase by imipramine and desimipramine. Biochem Pharmacol 23, 1138-1140 (1974)
4. Edwards DJ and Burns MO: Effects of tricyclic antidepressants upon human platelet monoamine oxidase. Life Sci 15, 2045-2058 (1974)
5. Egashira T, Takayama F and Yamanaka V: Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain. Gen Pharmacol 27, 773-778 (1996)
6. Egashira T, Yamamoto T and Yamanaka Y: Effects of d-methamphetamine on monkey brain monoamine oxidase, in vivo and in vitro. Jpn J Pharmacol 45, 79-88 (1987)
7. Egashira T and Yamanaka Y: Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal. Biochem Pharmacol 46, 609-614 (1993)
8. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275 (1951)
9. Roth JA and Gillis CN: Deamination of β-phenylethylamine by monoamine oxidase inhibition by imipramine. Biochem Pharmacol 23, 2537-2545 (1974)
10. Brown GK, Powell JF and Craig IW: Molecular weight differences between human platelet and placental monoamine oxidase. Biochem Pharmacol 29, 2595-2603 (1980)
11. Cawthon RM and Breakefield XO: Differences in the A and B forms of monoamine oxidase revealed by limited proteolysis and peptide mapping. Nature 282, 692-694 (1979)
12. Beckmann H and Riederer P: Monoamine oxidase and its selective inhibitors. In Modern Problems of Pharmacopsychiatry, Edited by Beckmann H and Riederer P, Vol 19, Karger, Basel (1983)
13. Johnston JP: Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17, 1288-1297 (1968)
14. Knoll J and Magyar K: Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5, 393-408 (1972)
15. 14C-deprenyl. Mol Pharmacol 16, 234-241 (1979)